BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 2460064)

  • 21. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.
    Hailemariam S; Gaspert A; Komminoth P; Tamboli P; Amin M
    Mod Pathol; 1998 Oct; 11(10):1016-20. PubMed ID: 9796733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV; Ali SZ
    Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinomas of the lung with neuroendocrine differentiation.
    Carter D; Yesner R
    Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review.
    Yashi M; Terauchi F; Nukui A; Ochi M; Yuzawa M; Hara Y; Morita T
    Urol Oncol; 2006; 24(4):313-7. PubMed ID: 16818183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.
    Casella R; Bubendorf L; Sauter G; Moch H; Mihatsch MJ; Gasser TC
    J Urol; 1998 Aug; 160(2):406-10. PubMed ID: 9679888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
    Abrahamsson PA; Cockett AT; di Sant'Agnese PA
    Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
    Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
    Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine differentiation in prostate cancer.
    Shariff AH; Ather MH
    Urology; 2006 Jul; 68(1):2-8. PubMed ID: 16844446
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases.
    Sigel JE; Goldblum JR
    Mod Pathol; 1998 Jun; 11(6):537-42. PubMed ID: 9647591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary renal carcinoid. Case report and literature review.
    Goldblum JR; Lloyd RV
    Arch Pathol Lab Med; 1993 Aug; 117(8):855-8. PubMed ID: 7688215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large cell carcinoma of the lung--ultrastructural and immunohistochemical studies.
    Kodama T; Shimosato Y; Koide T; Watanabe S; Teshima S
    Jpn J Clin Oncol; 1985 Jun; 15(2):431-41. PubMed ID: 2410641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine cells in the prostatic carcinomas after neoadjuvant hormonal therapy.
    Chen X; Okada H; Gotoh A; Arakawa S; Kamidono S
    Kobe J Med Sci; 1997 Apr; 43(2):71-81. PubMed ID: 9385786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Composite carcinoma of the prostate combining a small cell carcinoma and an adenocarcinoma. Apropos of a case].
    Kantelip B; Viallard JL; Costes-Chalret N; Francannet P
    Ann Pathol; 1989; 9(2):121-5. PubMed ID: 2544191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoid tumors of the gallbladder with adenocarcinomatous differentiation: a morphologic and immunohistochemical study.
    Noda M; Miwa A; Kitagawa M
    Am J Gastroenterol; 1989 Aug; 84(8):953-7. PubMed ID: 2756987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.